ReviewAesthetic surgery journal. Open forum2025
Optimizing Infraorbital Hollows Treatment With Hyaluronic Acid Fillers: Overview of Anatomy, Injection Techniques, and Product Considerations.
Review in Aesthetic surgery journal. Open forum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Given the importance of the periorbital area in facial expression and as an indicator of age, facial rejuvenation often needs to address infraorbital hollowing. Hyaluronic acid (HA) has become a treatment of choice in attenuating infraorbital grooves and smoothening the eyelid-cheek junction. This article (1) presents the definition and origin of infraorbital age-related landmarks, namely the midface, tear trough and palpebromalar groove, (2) reviews the anatomical characteristics and the course of neurovascular structures to delineate the treatment area, and (3) emphasizes the importance of choosing the right injection techniques and products for safe, effective, and natural-looking rejuvenation of the infraorbital area. Patient selection should rely on defined criteria, weighing the procedure's benefit vs the risk of implant irregularities or visibilities. To achieve natural-looking results, it is recommended to first address volume loss in the midface. If the outcomes are not satisfactory, direct treatment of infraorbital hollow can be performed using a maximum filler volume of 0.5 mL per eye, administered at the supraperiosteal level, through either a serial puncture injection or linear threading technique with a needle, or by using retrograde or anterograde linear threading or deposition of microboluses with a cannula. The choice of the HA filler should be based on its ability to adapt during facial movement; the filler should therefore be smooth, malleable, and present limited hygroscopicity.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.